Kenmerk
Broad forehead
Width of the forehead or distance between the frontotemporales is more than two standard deviations above the mean (objective); or apparently increased distance between the two sides of the forehead.
Samenvatting
- Ook bekend als
- Increased width of the forehead, Wide forehead, Bitemporal widening, Increased bitemporal dimension, Increased bitemporal width, Intertemporal widening
- Lichaamssysteem
- Abnormality of head or neck
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Broad forehead, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen224 genen gekoppeld aan Broad forehead
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Broad forehead voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Altijd | In 2 aandoeningen |
| ALPK3alpha kinase 3 | Altijd | In 1 aandoening |
| AMOTL1angiomotin like 1 | Altijd | In 1 aandoening |
| ANKHANKH inorganic pyrophosphate transport regulator | Altijd | In 1 aandoening |
| ANTXR1ANTXR cell adhesion molecule 1 | Altijd | In 2 aandoeningen |
| BUD13BUD13 spliceosome associated protein | Altijd | In 1 aandoening |
| CCDC22CCC complex scaffolding subunit CCDC22 | Altijd | In 1 aandoening |
| CHD8chromodomain helicase DNA binding protein 8 | Altijd | In 1 aandoening |
| DMRT2doublesex and mab-3 related transcription factor 2 | Altijd | In 1 aandoening |
| EMC10ER membrane protein complex subunit 10 | Altijd | In 1 aandoening |
| ESAMendothelial cell adhesion molecule | Altijd | In 1 aandoening |
| FBN1fibrillin 1 | Altijd | In 1 aandoening |
| IFIH1interferon induced with helicase C domain 1 | Altijd | In 1 aandoening |
| IGBP1immunoglobulin binding protein 1 | Altijd | In 1 aandoening |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Altijd | In 1 aandoening |
| JAG1jagged canonical Notch ligand 1 | Altijd | In 3 aandoeningen |
| KDM6Blysine demethylase 6B | Altijd | In 1 aandoening |
| MKS1MKS transition zone complex subunit 1 | Altijd | In 2 aandoeningen |
| NSD1nuclear receptor binding SET domain protein 1 | Altijd | In 2 aandoeningen |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Altijd | In 1 aandoening |
| POLR1ARNA polymerase I subunit A | Altijd | In 1 aandoening |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Altijd | In 1 aandoening |
| PTDSS1phosphatidylserine synthase 1 | Altijd | In 2 aandoeningen |
| PYCR1pyrroline-5-carboxylate reductase 1 | Altijd | In 1 aandoening |
| RLIMring finger protein, LIM domain interacting | Altijd | In 1 aandoening |
| ROBO1roundabout guidance receptor 1 | Altijd | In 1 aandoening |
| SATB2SATB homeobox 2 | Altijd | In 1 aandoening |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Altijd | In 1 aandoening |
| SKIC3SKI3 subunit of superkiller complex | Altijd | In 2 aandoeningen |
| SLC25A24solute carrier family 25 member 24 | Altijd | In 2 aandoeningen |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Altijd | In 2 aandoeningen |
| TBC1D32TBC1 domain family member 32 | Altijd | In 1 aandoening |
| TBC1D7TBC1 domain family member 7 | Altijd | In 1 aandoening |
| TOMM7translocase of outer mitochondrial membrane 7 | Altijd | In 1 aandoening |
| UBAP2Lubiquitin associated protein 2 like | Altijd | In 1 aandoening |
| UNC13Aunc-13 homolog A | Altijd | In 1 aandoening |
| WASHC5WASH complex subunit 5 | Altijd | In 1 aandoening |
| YY1YY1 transcription factor | Altijd | In 2 aandoeningen |
| AIPAHR interacting HSP90 co-chaperone | Heel vaak (80–99%) | In 1 aandoening |
| B4GALT7beta-1,4-galactosyltransferase 7 | Heel vaak (80–99%) | In 1 aandoening |
Toon nog 184 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Heel vaak (80–99%) | In 1 aandoening |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Heel vaak (80–99%) | In 1 aandoening |
| CAMTA1calmodulin binding transcription activator 1 | Heel vaak (80–99%) | In 1 aandoening |
| CCDC8coiled-coil domain containing 8 subunit of 3M complex | Heel vaak (80–99%) | In 1 aandoening |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Heel vaak (80–99%) | In 1 aandoening |
| CLIP2CAP-Gly domain containing linker protein 2 | Heel vaak (80–99%) | In 1 aandoening |
| CUL7cullin 7 | Heel vaak (80–99%) | In 1 aandoening |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Heel vaak (80–99%) | In 1 aandoening |
| EIF4Heukaryotic translation initiation factor 4H | Heel vaak (80–99%) | In 1 aandoening |
| ELNelastin | Heel vaak (80–99%) | In 2 aandoeningen |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Heel vaak (80–99%) | In 1 aandoening |
| FGFR2fibroblast growth factor receptor 2 | Heel vaak (80–99%) | In 3 aandoeningen |
| FGFR3fibroblast growth factor receptor 3 | Heel vaak (80–99%) | In 1 aandoening |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Heel vaak (80–99%) | In 1 aandoening |
| FLNAfilamin A | Heel vaak (80–99%) | In 1 aandoening |
| FLT4fms related receptor tyrosine kinase 4 | Heel vaak (80–99%) | In 1 aandoening |
| GATA4GATA binding protein 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| GATA5GATA binding protein 5 | Heel vaak (80–99%) | In 1 aandoening |
| GATA6GATA binding protein 6 | Heel vaak (80–99%) | In 2 aandoeningen |
| GDF1growth differentiation factor 1 | Heel vaak (80–99%) | In 1 aandoening |
| GJA5gap junction protein alpha 5 | Heel vaak (80–99%) | In 1 aandoening |
| GPC3glypican 3 | Heel vaak (80–99%) | In 1 aandoening |
| GPC4glypican 4 | Heel vaak (80–99%) | In 1 aandoening |
| GPR101G protein-coupled receptor 101 | Heel vaak (80–99%) | In 1 aandoening |
| GTF2Igeneral transcription factor IIi | Heel vaak (80–99%) | In 1 aandoening |
| GTF2IRD1GTF2I repeat domain containing 1 | Heel vaak (80–99%) | In 1 aandoening |
| GTF2IRD2GTF2I repeat domain containing 2 | Heel vaak (80–99%) | In 1 aandoening |
| KDRkinase insert domain receptor | Heel vaak (80–99%) | In 1 aandoening |
| LIMK1LIM domain kinase 1 | Heel vaak (80–99%) | In 1 aandoening |
| LRP5LDL receptor related protein 5 | Heel vaak (80–99%) | In 1 aandoening |
| MEF2Cmyocyte enhancer factor 2C | Heel vaak (80–99%) | In 2 aandoeningen |
| METTL27methyltransferase like 27 | Heel vaak (80–99%) | In 1 aandoening |
| NCF1neutrophil cytosolic factor 1 | Heel vaak (80–99%) | In 1 aandoening |
| NKX2-5NK2 homeobox 5 | Heel vaak (80–99%) | In 2 aandoeningen |
| NKX2-6NK2 homeobox 6 | Heel vaak (80–99%) | In 1 aandoening |
| OBSL1obscurin like cytoskeletal adaptor 1 | Heel vaak (80–99%) | In 1 aandoening |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Heel vaak (80–99%) | In 1 aandoening |
| POLR3ARNA polymerase III subunit A | Heel vaak (80–99%) | In 1 aandoening |
| RAI1retinoic acid induced 1 | Heel vaak (80–99%) | In 3 aandoeningen |
| RFC2replication factor C subunit 2 | Heel vaak (80–99%) | In 1 aandoening |
| RNF135ring finger protein 135 | Heel vaak (80–99%) | In 1 aandoening |
| SETBP1SET binding protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| STX1Asyntaxin 1A | Heel vaak (80–99%) | In 1 aandoening |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Heel vaak (80–99%) | In 1 aandoening |
| TBL2transducin beta like 2 | Heel vaak (80–99%) | In 1 aandoening |
| TBX1T-box transcription factor 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| TCF12transcription factor 12 | Heel vaak (80–99%) | In 1 aandoening |
| TMEM270transmembrane protein 270 | Heel vaak (80–99%) | In 1 aandoening |
| TWIST1twist family bHLH transcription factor 1 | Heel vaak (80–99%) | In 1 aandoening |
| VPS37DVPS37D subunit of ESCRT-I | Heel vaak (80–99%) | In 1 aandoening |
| ZBTB20zinc finger and BTB domain containing 20 | Heel vaak (80–99%) | In 1 aandoening |
| ZFPM2zinc finger protein, FOG family member 2 | Heel vaak (80–99%) | In 2 aandoeningen |
| ZIC1Zic family zinc finger 1 | Heel vaak (80–99%) | In 1 aandoening |
| ACTL6Bactin like 6B | Vaak (30–79%) | In 1 aandoening |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Vaak (30–79%) | In 1 aandoening |
| AHDC1AT-hook DNA binding motif containing 1 | Vaak (30–79%) | In 1 aandoening |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Vaak (30–79%) | In 1 aandoening |
| BMP1bone morphogenetic protein 1 | Vaak (30–79%) | In 1 aandoening |
| BMP2bone morphogenetic protein 2 | Vaak (30–79%) | In 1 aandoening |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Vaak (30–79%) | In 1 aandoening |
| CASKcalcium/calmodulin dependent serine protein kinase | Vaak (30–79%) | In 1 aandoening |
| CBLCbl proto-oncogene | Vaak (30–79%) | In 1 aandoening |
| CCBE1collagen and calcium binding EGF domains 1 | Vaak (30–79%) | In 2 aandoeningen |
| CDH11cadherin 11 | Vaak (30–79%) | In 1 aandoening |
| CDKL5cyclin dependent kinase like 5 | Vaak (30–79%) | In 2 aandoeningen |
| CHST3carbohydrate sulfotransferase 3 | Vaak (30–79%) | In 3 aandoeningen |
| CKAP2Lcytoskeleton associated protein 2L | Vaak (30–79%) | In 2 aandoeningen |
| DPH5diphthamide biosynthesis 5 | Vaak (30–79%) | In 1 aandoening |
| FAT4FAT atypical cadherin 4 | Vaak (30–79%) | In 1 aandoening |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| FUT8fucosyltransferase 8 | Vaak (30–79%) | In 1 aandoening |
| GATAD2BGATA zinc finger domain containing 2B | Vaak (30–79%) | In 2 aandoeningen |
| HBA1hemoglobin subunit alpha 1 | Vaak (30–79%) | In 1 aandoening |
| HBA2hemoglobin subunit alpha 2 | Vaak (30–79%) | In 1 aandoening |
| HOXB1homeobox B1 | Vaak (30–79%) | In 1 aandoening |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Vaak (30–79%) | In 1 aandoening |
| KIF7kinesin family member 7 | Vaak (30–79%) | In 1 aandoening |
| LRP2LDL receptor related protein 2 | Vaak (30–79%) | In 1 aandoening |
| MAP2K1mitogen-activated protein kinase kinase 1 | Vaak (30–79%) | In 1 aandoening |
| MBD5methyl-CpG binding domain protein 5 | Vaak (30–79%) | In 2 aandoeningen |
| NFIXnuclear factor I X | Vaak (30–79%) | In 1 aandoening |
| NRASNRAS proto-oncogene, GTPase | Vaak (30–79%) | In 2 aandoeningen |
| PAN2poly(A) specific ribonuclease subunit PAN2 | Vaak (30–79%) | In 1 aandoening |
| POGZpogo transposable element derived with ZNF domain | Vaak (30–79%) | In 1 aandoening |
| POLEDNA polymerase epsilon, catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| PPM1Dprotein phosphatase, Mg2+/Mn2+ dependent 1D | Vaak (30–79%) | In 1 aandoening |
| PRIM1DNA primase subunit 1 | Vaak (30–79%) | In 1 aandoening |
| PTBP1polypyrimidine tract binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Vaak (30–79%) | In 1 aandoening |
| RBM8ARNA binding motif protein 8A | Vaak (30–79%) | In 1 aandoening |
| RYR3ryanodine receptor 3 | Vaak (30–79%) | In 1 aandoening |
| SH3PXD2BSH3 and PX domains 2B | Vaak (30–79%) | In 1 aandoening |
| SIN3ASIN3 transcription regulator family member A | Vaak (30–79%) | In 1 aandoening |
| SKIC2SKI2 subunit of superkiller complex | Vaak (30–79%) | In 1 aandoening |
| SMAD2SMAD family member 2 | Vaak (30–79%) | In 1 aandoening |
| STEEP1STING1 ER exit protein 1 | Vaak (30–79%) | In 1 aandoening |
| TCEAL1transcription elongation factor A like 1 | Vaak (30–79%) | In 1 aandoening |
| TRPM3transient receptor potential cation channel subfamily M member 3 | Vaak (30–79%) | In 1 aandoening |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Vaak (30–79%) | In 1 aandoening |
| ACTG2actin gamma 2, smooth muscle | Soms (5–29%) | In 1 aandoening |
| CDC42BPBCDC42 binding protein kinase beta | Soms (5–29%) | In 1 aandoening |
| CDH2cadherin 2 | Soms (5–29%) | In 1 aandoening |
| CUX1cut like homeobox 1 | Soms (5–29%) | In 1 aandoening |
| DLK1delta like non-canonical Notch ligand 1 | Soms (5–29%) | In 1 aandoening |
| DLL3delta like canonical Notch ligand 3 | Soms (5–29%) | In 1 aandoening |
| DPP9dipeptidyl peptidase 9 | Soms (5–29%) | In 1 aandoening |
| EBF3EBF transcription factor 3 | Soms (5–29%) | In 2 aandoeningen |
| FBLN5fibulin 5 | Soms (5–29%) | In 1 aandoening |
| FBXO11F-box protein 11 | Soms (5–29%) | In 1 aandoening |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Soms (5–29%) | In 1 aandoening |
| HES7hes family bHLH transcription factor 7 | Soms (5–29%) | In 1 aandoening |
| HIVEP2HIVEP zinc finger 2 | Soms (5–29%) | In 1 aandoening |
| IDH1isocitrate dehydrogenase (NADP(+)) 1 | Soms (5–29%) | In 1 aandoening |
| JARID2jumonji and AT-rich interaction domain containing 2 | Soms (5–29%) | In 1 aandoening |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Soms (5–29%) | In 1 aandoening |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Soms (5–29%) | In 2 aandoeningen |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Soms (5–29%) | In 1 aandoening |
| KDM2Blysine demethylase 2B | Soms (5–29%) | In 1 aandoening |
| LFNGLFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | Soms (5–29%) | In 1 aandoening |
| MADDMAP kinase activating death domain | Soms (5–29%) | In 1 aandoening |
| MAN2B1mannosidase alpha class 2B member 1 | Soms (5–29%) | In 2 aandoeningen |
| MARK2microtubule affinity regulating kinase 2 | Soms (5–29%) | In 1 aandoening |
| MED13Lmediator complex subunit 13L | Soms (5–29%) | In 1 aandoening |
| MEG3maternally expressed 3 | Soms (5–29%) | In 1 aandoening |
| MESP2mesoderm posterior bHLH transcription factor 2 | Soms (5–29%) | In 1 aandoening |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Soms (5–29%) | In 1 aandoening |
| NALCNsodium leak channel, non-selective | Soms (5–29%) | In 1 aandoening |
| NARS1asparaginyl-tRNA synthetase 1 | Soms (5–29%) | In 1 aandoening |
| NF1neurofibromin 1 | Soms (5–29%) | In 1 aandoening |
| NIPA1NIPA magnesium transporter 1 | Soms (5–29%) | In 1 aandoening |
| NIPA2NIPA magnesium transporter 2 | Soms (5–29%) | In 1 aandoening |
| ODC1ornithine decarboxylase 1 | Soms (5–29%) | In 1 aandoening |
| PIGUphosphatidylinositol glycan anchor biosynthesis class U | Soms (5–29%) | In 1 aandoening |
| PPP2CAprotein phosphatase 2 catalytic subunit alpha | Soms (5–29%) | In 1 aandoening |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Soms (5–29%) | In 1 aandoening |
| PSPHphosphoserine phosphatase | Soms (5–29%) | In 1 aandoening |
| RAB34RAB34, member RAS oncogene family | Soms (5–29%) | In 1 aandoening |
| RECQL4RecQ like helicase 4 | Soms (5–29%) | In 1 aandoening |
| RIPPLY2ripply transcriptional repressor 2 | Soms (5–29%) | In 1 aandoening |
| RPL10ribosomal protein L10 | Soms (5–29%) | In 1 aandoening |
| RTL1retrotransposon Gag like 1 | Soms (5–29%) | In 1 aandoening |
| RUNX2RUNX family transcription factor 2 | Soms (5–29%) | In 1 aandoening |
| SCNM1sodium channel modifier 1 | Soms (5–29%) | In 1 aandoening |
| SH2B1SH2B adaptor protein 1 | Soms (5–29%) | In 1 aandoening |
| SIM1SIM bHLH transcription factor 1 | Soms (5–29%) | In 1 aandoening |
| SLC26A2solute carrier family 26 member 2 | Soms (5–29%) | In 1 aandoening |
| TBCBtubulin folding cofactor B | Soms (5–29%) | In 1 aandoening |
| TBCKTBC1 domain containing kinase | Soms (5–29%) | In 2 aandoeningen |
| TBX6T-box transcription factor 6 | Soms (5–29%) | In 1 aandoening |
| TCTN2tectonic family member 2 | Soms (5–29%) | In 1 aandoening |
| THOC2THO complex subunit 2 | Soms (5–29%) | In 1 aandoening |
| THOC6THO complex subunit 6 | Soms (5–29%) | In 1 aandoening |
| TTC5tetratricopeptide repeat domain 5 | Soms (5–29%) | In 1 aandoening |
| TUBG1tubulin gamma 1 | Soms (5–29%) | In 1 aandoening |
| WACWW domain containing adaptor with coiled-coil | Soms (5–29%) | In 2 aandoeningen |
| WBP11WW domain binding protein 11 | Soms (5–29%) | In 1 aandoening |
| WDR83OSWD repeat domain 83 opposite strand | Soms (5–29%) | In 1 aandoening |
| ZFXzinc finger protein X-linked | Soms (5–29%) | In 1 aandoening |
| ZIC2Zic family zinc finger 2 | Soms (5–29%) | In 1 aandoening |
| CNTNAP2contactin associated protein 2 | Zelden (1–4%) | In 1 aandoening |
| SPTBN1spectrin beta, non-erythrocytic 1 | Zelden (1–4%) | In 1 aandoening |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Niet vastgelegd | In 1 aandoening |
| AMMECR1AMMECR nuclear protein 1 | Niet vastgelegd | In 1 aandoening |
| CCNQcyclin Q | Niet vastgelegd | In 1 aandoening |
| CHST14carbohydrate sulfotransferase 14 | Niet vastgelegd | In 1 aandoening |
| COLEC11collectin subfamily member 11 | Niet vastgelegd | In 1 aandoening |
| DNMT3ADNA methyltransferase 3 alpha | Niet vastgelegd | In 1 aandoening |
| EEDembryonic ectoderm development | Niet vastgelegd | In 1 aandoening |
| FLCNfolliculin | Niet vastgelegd | In 1 aandoening |
| HRASHRas proto-oncogene, GTPase | Niet vastgelegd | In 1 aandoening |
| KRASKRas proto-oncogene, GTPase | Niet vastgelegd | In 1 aandoening |
| NFIAnuclear factor I A | Niet vastgelegd | In 1 aandoening |
| NOTCH2notch receptor 2 | Niet vastgelegd | In 1 aandoening |
| PAK1p21 (RAC1) activated kinase 1 | Niet vastgelegd | In 1 aandoening |
| PCGF2polycomb group ring finger 2 | Niet vastgelegd | In 1 aandoening |
| PEX3peroxisomal biogenesis factor 3 | Niet vastgelegd | In 1 aandoening |
| PIGBphosphatidylinositol glycan anchor biosynthesis class B | Niet vastgelegd | In 1 aandoening |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Niet vastgelegd | In 1 aandoening |
| PTENphosphatase and tensin homolog | Niet vastgelegd | In 1 aandoening |
| SLC6A8solute carrier family 6 member 8 | Niet vastgelegd | In 1 aandoening |
| TENT5Aterminal nucleotidyltransferase 5A | Niet vastgelegd | In 1 aandoening |
| TET3tet methylcytosine dioxygenase 3 | Niet vastgelegd | In 1 aandoening |
| TFAP2Btranscription factor AP-2 beta | Niet vastgelegd | In 1 aandoening |
| UNC80unc-80 subunit of NALCN channel complex | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken